PetVivo Holdings, Inc. (PETV) stock
PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.75+0.00 (0.00%)
Close on Oct 19, 2026Market cap $27.79MP/E –Yield –
PetVivo gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
PetVivo's gross profit for the twelve months ending Jun 30, 2026 was $791.34K, down 26.1% year over year. For fiscal 2026 it was $754.75K, down 24.1% from the year before. Over ten years it grew 26.0% a year on average. The highest annual figure on record is $994.86K in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $754.75K | -24.1% |
| FY2025 | Mar 31, 2025 | $994.86K | +14.8% |
| FY2024 | Mar 31, 2024 | $866.88K | +24.5% |
| FY2023 | Mar 31, 2023 | $696.13K | – |
| FY2022 | Mar 31, 2022 | -$85.57K | -4644.2% |
| FY2021 | Mar 31, 2021 | $1.88K | – |
| FY2020 | Mar 31, 2020 | -$16.12K | – |
| FY2019 | Mar 31, 2019 | -$77.94K | -5261.3% |
| FY2018 | Mar 31, 2018 | $1.51K | -78.8% |
| FY2017 | Mar 31, 2017 | $7.12K | -90.5% |
| FY2016 | Mar 31, 2016 | $75.00K | – |
| FY2012 | Mar 31, 2012 | $0 | – |
| FY2011 | Mar 31, 2011 | $0 | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $223.32K | +19.6% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $203.26K | +11.2% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $144.71K | -72.3% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $220.06K | +22.6% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $186.73K | +68.6% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $182.73K | +324.1% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $521.82K | -2.2% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $179.56K | -3.2% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $110.76K | +5.6% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $43.09K | -86.9% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $533.32K | +86.2% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $185.50K | +146.9% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $104.88K | +1934.9% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $329.43K | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $286.42K | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $75.12K | +1409.4% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $5.15K | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$41.65K | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$47.99K | -9566.1% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $4.98K | +12.1% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$906 | -145.2% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$5.07K | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $507 | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $4.44K | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $2.01K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$10.63K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$1.65K | -603.1% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$3.85K | -425.0% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $0 | -100.0% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $0 | -100.0% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $327 | -88.8% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $1.18K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $45 | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $2.16K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $2.91K | – |
See a number that looks wrong?